Voglicare-MG 3 Tablet ER
By Voglicare-MG
Rx
15 Tablet ER in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Care Formulation Labs Pvt Ltd
D-1659, DSIIDC, Narela Industrial Area, Delhi, 110040

Expires on or after
November, 2025

liver
When using Voglicare-MG 3 Tablet ER, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Voglicare-MG 3 Tablet ER. It is advised to consult your doctor before starting this medication. Particularly in cases of mild to moderate liver disease, Voglicare-MG 3 Tablet ER is usually initiated at a low dose. However, it is not recommended for use in patients with severe liver disease.

kidney
Voglicare-MG 3 Tablet ER should be avoided in patients with kidney disease. It is not recommended for those with severe kidney disease. Consulting your doctor is advised before using this medication.

alcohol
It is not safe to consume alcohol with Voglicare-MG 3 Tablet ER. Make sure to avoid alcohol while taking this medication.

driving
Driving while taking Voglicare-MG 3 Tablet ER may be unsafe if you experience low or high blood sugar levels. Avoid driving if you notice these symptoms.

pregnancy
Voglicare-MG 3 Tablet ER may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a careful evaluation before considering this medication.

breastfeeding
Voglicare-MG 3 Tablet ER should be avoided during breastfeeding as it may pass into the breastmilk and potentially harm the baby. It is advised to consult a doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹110
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024